Chief Executive Officer
Gusten R. (Bud) Brainerd has over thirty years of successful experience as a leader of leaders in both corporate and non-profit arenas. In addition to having served and chaired numerous boards his work has included serving as founder and CEO of two technology companies, coaching senior level executives in small and mid-sized privately held companies, and consulting for rapid growth companies.
Mr. Brainerd earned his BA from McKendree University, his M.Div. and D.Min. from Columbia Theological Seminary writing his dissertation on W. Edward Deming’s management theory. He is certified by the Center for Executive Coaching as an Executive Coach and as a Gallup Coach.
Founder & Chairman, Board of Directors
Cliff Wright is the Founder of Octet and the inventor of OMEA. Mr. Wright is an accomplished entrepreneur with over 96 patents published, 84 patents granted, and 30 patents pending. He has been published in the Journal of Medicine for the first design of a medical transport delivery system published in the journal of pulmonary medicine for the heated filtration system extracorporeal membrane oxygenation.
Mr. Wright is the founder and chief technical officer of Victory Innovations where he had created the world’s first cordless electrostatic sprayers which has been commercialized into 50 states and 40 countries. Mr. Wright has served on several medical device boards where he has used is experience in manufacturing and engineering to increase shareholder value.
Mr. Wright earned a bachelor’s degree in Mechanical Engineering from Arizona State University.
Chief Science Officer
Mr. Ortuno has 25 plus years of academic and pharmaceutical experience and has been involved in early therapeutic target validation to first in human trials and eventual FDA approval. He has held leadership positions in the scientific function at Arena Pharmaceuticals, Amgen, and Novartis.
Dan Ortuno graduated from the University of California San Diego, with an emphasis in Cell Biology and Biochemistry. He continued his academic endeavors at the Salk Institute working with Professor Greg Lemke in the Molecular Neurobiology Lab.
Chief Technical Officer
Mr. Elsabee brings fifteen years of experience in medical devices and the delivery of electrostatically charged fluids. As a biomedical engineer, he has led large teams of engineers in multiple system development projects simultaneously through the product development cycle from concept through production launch complying with ISO 13485 & FDA QSR. Prior to Octet Kyle served as Senior Program Engineer for Victory Innovations, Senior Product Development Engineer for Symbient, and Product Development Manager for Spinal Elements and Spine Frontier.
Mr. Elsabee earned a BS and MS in Biomedical Engineering from Rensselaer Polytechnic Institute (RPI), Troy, NY.